In agreement with these observations, we provided additional evidence that Sp1 and NF-kappa B, transcriptional activated by E2F1, promoted aggressive phenotype via upregulation of MMP-9 that was highly expressed in SCLC. The gene discussed is SP1; the disease is small cell lung carcinoma.